Previous product
Back to products
Monjuvi (tafasitamab-cxix)
CHF4,160.00
Next product
Inqovi (decitabine and cedazuridine)
CHF13,520.00
Tabrecta (capmatinib)
CHF13,957.89
Tabrecta (capmatinib) is a medication used for the treatment of adults with metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14).
Reviews
There are no reviews yet.